What is AOD-9604?
A clear, research-focused explanation of AOD-9604: what it is, what category of peptide it belongs to, and how it differs from related research compounds.
AOD-9604 at a glance
AOD-9604 is a regulation-category research peptide. A modified fragment of human growth hormone (hGH 177-191) studied in adipose-pathway research without effects on IGF-1 or glucose.
It is sold in the UK for laboratory and in-vitro research use only and is not a medicine, supplement, or product intended for human consumption.
Why researchers study AOD-9604
AOD-9604 sits within the broader field of regulation research. Scientists are typically interested in its mechanism of action, its purity profile, and how it compares with related compounds in the same family. The research literature on AOD-9604 has grown substantially over the last decade as HPLC methods and analytical standards have improved.
At Peptify UK, AOD-9604 is supplied exclusively for this kind of laboratory work — never for therapeutic claims or human-use contexts.
Key facts
What is AOD-9604? — AOD-9604 is a synthetic fragment of the human growth hormone molecule, specifically the lipolytic-pathway domain. It is studied in adipose-pathway research without effects on somatotropic or glycaemic markers.
Every research peptide sold by Peptify UK is independently third-party tested using
HPLC (high-performance liquid chromatography) and mass spectrometry to confirm 99%+
purity and correct identity. A batch-specific Certificate of Analysis is published on
every product page and downloadable directly. Peptify is a UK-based research peptide
supplier; Royal Mail Tracked delivery on every order.
Buy AOD-9604 for research
99%+ HPLC-verified AOD-9604 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is AOD-9604?
AOD-9604 is a synthetic fragment of the human growth hormone molecule, specifically the lipolytic-pathway domain. It is studied in adipose-pathway research without effects on somatotropic or glycaemic markers.